Protective effects of a mixture of antioxidant vitamins and minerals on the genotoxicity of doxorubicin in somatic cells of Drosophila melanogaster

Environmental and Molecular Mutagenesis

Volumn 47, Issue 1, 2006, Pages 18-24

  Costa, Wender Ferreira ^a   Nepomuceno, Júlio César ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Antigenotoxicity; Doxorubicin; Drosophila melanogaster; Multivitamin

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; COPPER; DOXORUBICIN; FREE RADICAL; MINERAL; MULTIVITAMIN; SELENIUM; VITERGAN ZINC PLUS; ZINC;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; DRUG MECHANISM; FLY; GENOTOXICITY; HETEROZYGOSITY; LARVA; NONHUMAN; SOMATIC CELL; STATISTICAL SIGNIFICANCE; TOXICITY TESTING;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; COPPER; DOXORUBICIN; DROSOPHILA MELANOGASTER; FEMALE; LARVA; MALE; MUTAGENS; MUTATION; SELENIUM; VITAMIN E; WING; ZINC;

DROSOPHILA MELANOGASTER;

EID: 32544443006     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.20160     Document Type: Article

References (30)

1. Abraham SK. 1994. Antigenotoxicity of coffee in the Drosophila assay for somatic mutation and recombination. Mutagenesis 9:383-386.
2. Abraham SK, Graf U. 1996. Protection by coffee against somatic genotoxicity in Drosophila: role of bioactivation capacity. Food Chem Toxic 34:1-14.
3. Amara-Mokrane YA. Lehucher-Michel MP, Balasard G, Dumenil G, Botta A. 1996. Protective effects of α-hederin, chlorophyllin and ascorbic acid towards the induction of micronuclei by doxorubicin in cultured human lymphocytes. Mutagenesis 11:161-167.
4. Antunes LMG, Takahashi CS. 1998. Effects of high doses of vitamins C and E against doxorubicin induced chromosomal damage in Wistar rat bone marrow cells. Mutat Res 419:137-143.
5. Fenech M, Ferguson LR. 2001. Vitamins/minerals and genomic stability in humans. Mutat Res 475:1-6.
6. Frei H, Würgler FE. 1995. Optimal experimental design and sample size for the statistical evaluation of data from somatic mutation and recombination test (SMART) in Drosophila. Mutat Res 334:247-258.
7. Fragiorge, EJ. 2000. Efeitos moduladores do ácido ascórbico quando associado ao cloridrato de doxorrubicina em células somáticas de Drosophila melanogaster, tratadas na presença ou ausência de luz. Dissertação de Mestrado, Universidade Federal de Uberlândia. Uberlândia, MG. 87p.
8. Graf U, Van Schaik N. 1992. Improved high bioactivation cross for the wing somatic mutation and recombination test in Drosophila melanogaster. Mutat Res 271:59-67.
9. Graf U, Würgler FE, Katz AJ, Frei H, Juon H, Hall CB, Kale PG. 1984. Somatic mutation and recombination test in Drosophila melanogaster. Environ Mutagen 6:153-188.
10. Graf U, Frei H, Kägi A, Katz AJ, Würgler FE. 1989. Thirty compounds tested in the Drosophila wing spot test. Mutat Res 222:359-373.
11. Graf U, Abraham SK, Guzmán-Rincón J, Würgler FE. 1998. Antigenotoxicity studies in Drosophila melanogaster. Mutat Res 402:203-209.
12. Halliwell B. 1994. Free radicals and antioxidants: a personal view. Nutr Rev 52:253-265.
13. Hussein AM. 1993. Chemotherapy-induced alopecia: new developments. South Med J 86:489-496.
14. Kada T, Inoue T, Namiki M. 1982. Environmental desmutagens and antimutagens. In: Klekowski EJ, Jr., editor. Environmental Mutagenesis. Carcinogenesis and Plant Biology. New York: Praeger. pp 133-152.
15. Kasai H. 2002. Chemistry-based studies on oxidative DNA damage: formation, repair, and mutagenesis. Free Radic Biol Med 33:450-456.
16. Keizer HG, Pinedo HM, Schuurhuis GJ, Joenje H. 1990. Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol Ther 47:219-231.
17. Konopacka M, Widel M, Rzeszowska-Wolny J. 1998. Modifying effect of vitamins C, E and β-carotene against γ-ray-induced DNA damage in mouse cells. Mutat Res 417:85-94.
18. Korac B, Buzadzic B. 2001. Doxorubicin toxicity to the skin: possibility of protection with antioxidants enriched yeast. J Dermatol Sci 25: 45-52.
19. Kuroda Y, Shima N, Yazawa K, Kaji K. 2001. Desmutagenic and bio-antimutagenic activity of docosahexaenoic acid and eicosapentaenoic acid in cultured Chinese hamster V79 cells. Mutat Res 497:123-130.
20. Lamson DW, Brignall MS. 1999. Antioxidants in cancer therapy; their actions and interactions with oncologic therapies. Altem Med Rev 4:304-329.
21. Lee KW, Lee HJ, Lee CY. 2004. Vitamins, phytochemicals, diets, and their implementation in cancer chemoprevention. Crit Rev Food Sci Nutr 44(6):437-452.
22. Lehmann M, Franco A, Vilar KSP, Lukza-Reguly M, Andrade HH. 2003. Doxorubicin and two of its analogues are preferential inducers of homologous recombination compared with mutational events in somatic cells of Drosophila melanogaster. Mutat Res 539:167-175.
23. López-Buriiio S, Tan DX, Mayo JC, Sains RM, Manchester LC, Reiter RJ. 2003. Melatonin, xanthurenic acid, resveratrol, EGCC, vitamin C, α-lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents: a study of their individual and synergistic actions. J Pineal Res 34:269-277.
24. Odin AP. 1997. Vitamins as antimutagens: advantages and some possible mechanisms of antimutagenic action. Mutat Res 386:39-67.
25. Picada JN, Kern AL, Ramos LLP, Saffi J. 2003. O extresse oxidativo e as defesas antioxidantes. In: Genética Toxicológica. Porto Alegre: Alcance. pp 251-264.
26. Pyrhonen S, Kuitunen T, Nyandoto P, Kouri M. 1995. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71:587-591.
27. Ramji S, Lee C, Inaba T, Patterson AV, Riddick DS. 2003. Human NADPH-cytochrome P-450 reductase overexpression does not enhance the aerobic cytotoxicity of doxorubicin in human breast cancer cell lines. Cancer Res 63:6914-6919.
28. Reiter RJ. 1995. Oxidative process and antioxidative defense mechanisms in the aging brain. FASEB J 9:526-533.
29. Rodriguez-Arnaiz R, Sortibran AC, Tellez GO. 2004. Detection of mitotic recombination and sex chromosome loss induced by adriamycin, chlorambucil, demecolcine, paclitaxel and vinblastine in somatic cells of Drosophila melanogaster in vivo. Mutagenesis 19:121-127.
30. Würgler FE, Sobels FH, Vogel E. 1984. Drosophila as an assay system for detecting genetic changes. In: Handbook of Mutagenicity Test Procedures. Amsterdam: Elsevier, pp 555-601.